Cas:69659-80-9 Tanshinone IIA sodium sulfonate manufacturer & supplier

Chemical Name:Tanshinone IIA sodium sulfonate

CAS.NO:69659-80-9

Synonyms:sodium,1,6,6-trimethyl-10,11-dioxo-8,9-dihydro-7H-naphtho[1,2-g][1]benzofuran-2-sulfonate;Sodium 1,6,6-trimethyl-10,11-dioxo-6,7,8,9,10,11-hexahydrophenanthro[1,2-b]furan-2-sulfonate;Phenanthro[1,2-b]furan-2-sulfonic acid, 6,7,8,9,10,11-hexahydro-1,6,6-trimethyl-10,11-dioxo-, sodium salt (1:1);Tanshinone IIA sulfonate (sodium);Sulfotanshinone sodium II-A

Molecular Formula:C₁₉H₁₇NaO₆S

Molecular Weight:396.389

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:112.86000

Exact Mass:396.064362

LogP:4.23280

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like sodium,1,6,6-trimethyl-10,11-dioxo-8,9-dihydro-7H-naphtho[1,2-g][1]benzofuran-2-sulfonate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Sulfotanshinone sodium II-A physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Phenanthro[1,2-b]furan-2-sulfonic acid, 6,7,8,9,10,11-hexahydro-1,6,6-trimethyl-10,11-dioxo-, sodium salt (1:1) Use and application,Tanshinone IIA sulfonate (sodium) technical grade,usp/ep/jp grade.

Related News: INSPIRE is a global, multi-center, randomized, controlled study to assess the efficacy and safety of IV rigosertib in higher-risk MDS (HR-MDS) patients who had progressed on, failed to respond to, or relapsed after previous treatment with a hypomethylating agent (HMA) within nine cycles over the course of one year after initiation of HMA treatment. Tanshinone IIA sodium sulfonate manufacturer Patients given the vaccine also experienced a reduction in cerebrospinal fluid biomarkers of abnormal tau, results show. Tanshinone IIA sodium sulfonate supplier Like SARS, this latest outbreak is caused by a coronavirus, a family of viruses common to animals that range from the common cold, to more serious diseases, like Middle East respiratory syndrome (MERS). Tanshinone IIA sodium sulfonate vendor Zhejiang Tianyu Co., Ltd .: It is mainly engaged in the research and development and production of sartan-type APIs and intermediates. It has serialized sartan-type APIs and intermediate products, and has accumulated rich chemical synthesis technology. It has strong technical advantages and Scale advantage. Tanshinone IIA sodium sulfonate factory INSPIRE is a global, multi-center, randomized, controlled study to assess the efficacy and safety of IV rigosertib in higher-risk MDS (HR-MDS) patients who had progressed on, failed to respond to, or relapsed after previous treatment with a hypomethylating agent (HMA) within nine cycles over the course of one year after initiation of HMA treatment.